FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1526098730> ?p ?o ?g. }

• W1526098730 endingPage "8" @default.
• W1526098730 startingPage "1" @default.
• W1526098730 abstract "Polyoma BK virus nephropathy (PVN) is a leading cause of renal allograft injury and loss. The mainstay of treatment, as there are no target therapies approved by the US Food & Drug Administration, is reduction in immunosuppression. However, current approaches are shifting to screening for viremia as an indicator of oncoming nephropathy, with subsequent reduction in immunotherapy. We attempted not only to replicate these data but also to evaluate the utility of polyoma viremia as a surrogate marker for overimmunosuppression in general, thus allowing prevention not only of PVN but also of other viral opportunistic infections such as cytomegalovirus (CMV) and Epstein-Barr virus (EBV) disease.We conducted a retrospective cohort analysis of renal transplant recipients at our center. The historical controls (2003-2005, n = 134) had received their allograft before the institution of a monthly serum polymerase chain reaction (PCR) polyoma screening protocol. The screened cohort received their allograft afterwards (2006-2008, n=134). Screening was performed using PCR techniques with prompt reduction in immunosuppression for viremic patients. The patients were followed for the development of PVN, acute rejection, renal allograft function, and survival.Polyoma viremia was noted in 16% of the screened population, with none developing PVN after prompt reduction of immunosuppression. Clearance of the viremia occurred by 6 months in 95% of the patients after reduction of immunotherapy. No patient in the screened group developed CMV or EBV disease. Of the controls, 7 (5%) developed PVN and 12 (9%) developed CMV or EBV disease, compared with none of the screened patients (P<0.05). The incidence of acute rejection was comparable between the groups (4% controls, 5% screened). No deleterious effects were noted on patient or allograft survival, allograft function (measured by serum creatinine), rates of fungal infection, or the rate of post-transplant lymphoproliferative disorder in the screened patients.Monthly PCR monitoring for BK viremia, together with a modest decrease in immunotherapy, is not only safe but also effectively prevents PVN and is associated with a significantly decreased rate of CMV and EBV disease in renal transplant patients. BK viremia may also serve as a surrogate marker for overimmunosuppression." @default.
• W1526098730 created "2016-06-24" @default.
• W1526098730 creator A5020235583 @default.
• W1526098730 creator A5028148025 @default.
• W1526098730 creator A5029823540 @default.
• W1526098730 creator A5081141751 @default.
• W1526098730 date "2010-08-17" @default.
• W1526098730 modified "2023-09-27" @default.
• W1526098730 title "Initiation of a screening protocol for polyoma virus results in a decreased rate of opportunistic non-BK viral disease after renal transplantation" @default.
• W1526098730 cites W1743283402 @default.
• W1526098730 cites W1966875430 @default.
• W1526098730 cites W1970342204 @default.
• W1526098730 cites W1970398913 @default.
• W1526098730 cites W1974085494 @default.
• W1526098730 cites W1986922319 @default.
• W1526098730 cites W1994960623 @default.
• W1526098730 cites W1996556561 @default.
• W1526098730 cites W1998312138 @default.
• W1526098730 cites W2004876280 @default.
• W1526098730 cites W2026399575 @default.
• W1526098730 cites W2035597292 @default.
• W1526098730 cites W2046462591 @default.
• W1526098730 cites W2049970707 @default.
• W1526098730 cites W2084881503 @default.
• W1526098730 cites W2088168913 @default.
• W1526098730 cites W2098856442 @default.
• W1526098730 cites W2103423248 @default.
• W1526098730 cites W2103531089 @default.
• W1526098730 cites W2105823869 @default.
• W1526098730 cites W2118817245 @default.
• W1526098730 cites W2129471626 @default.
• W1526098730 cites W2137144600 @default.
• W1526098730 cites W2162237759 @default.
• W1526098730 doi "https://doi.org/10.1111/j.1399-3062.2010.00548.x" @default.
• W1526098730 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20723175" @default.
• W1526098730 hasPublicationYear "2010" @default.
• W1526098730 type Work @default.
• W1526098730 sameAs 1526098730 @default.
• W1526098730 citedByCount "10" @default.
• W1526098730 countsByYear W15260987302012 @default.
• W1526098730 countsByYear W15260987302013 @default.
• W1526098730 countsByYear W15260987302015 @default.
• W1526098730 countsByYear W15260987302020 @default.
• W1526098730 crossrefType "journal-article" @default.
• W1526098730 hasAuthorship W1526098730A5020235583 @default.
• W1526098730 hasAuthorship W1526098730A5028148025 @default.
• W1526098730 hasAuthorship W1526098730A5029823540 @default.
• W1526098730 hasAuthorship W1526098730A5081141751 @default.
• W1526098730 hasConcept C126322002 @default.
• W1526098730 hasConcept C159047783 @default.
• W1526098730 hasConcept C203014093 @default.
• W1526098730 hasConcept C2522874641 @default.
• W1526098730 hasConcept C2776185481 @default.
• W1526098730 hasConcept C2778199330 @default.
• W1526098730 hasConcept C2779134260 @default.
• W1526098730 hasConcept C2780252810 @default.
• W1526098730 hasConcept C2780303639 @default.
• W1526098730 hasConcept C2908647359 @default.
• W1526098730 hasConcept C2909782663 @default.
• W1526098730 hasConcept C2911091166 @default.
• W1526098730 hasConcept C71924100 @default.
• W1526098730 hasConcept C99454951 @default.
• W1526098730 hasConceptScore W1526098730C126322002 @default.
• W1526098730 hasConceptScore W1526098730C159047783 @default.
• W1526098730 hasConceptScore W1526098730C203014093 @default.
• W1526098730 hasConceptScore W1526098730C2522874641 @default.
• W1526098730 hasConceptScore W1526098730C2776185481 @default.
• W1526098730 hasConceptScore W1526098730C2778199330 @default.
• W1526098730 hasConceptScore W1526098730C2779134260 @default.
• W1526098730 hasConceptScore W1526098730C2780252810 @default.
• W1526098730 hasConceptScore W1526098730C2780303639 @default.
• W1526098730 hasConceptScore W1526098730C2908647359 @default.
• W1526098730 hasConceptScore W1526098730C2909782663 @default.
• W1526098730 hasConceptScore W1526098730C2911091166 @default.
• W1526098730 hasConceptScore W1526098730C71924100 @default.
• W1526098730 hasConceptScore W1526098730C99454951 @default.
• W1526098730 hasIssue "1" @default.
• W1526098730 hasLocation W15260987301 @default.
• W1526098730 hasLocation W15260987302 @default.
• W1526098730 hasOpenAccess W1526098730 @default.
• W1526098730 hasPrimaryLocation W15260987301 @default.
• W1526098730 hasRelatedWork W2150422991 @default.
• W1526098730 hasRelatedWork W2205973852 @default.
• W1526098730 hasRelatedWork W2327414686 @default.
• W1526098730 hasRelatedWork W2554808435 @default.
• W1526098730 hasRelatedWork W2588128012 @default.
• W1526098730 hasRelatedWork W2616661574 @default.
• W1526098730 hasRelatedWork W2804526758 @default.
• W1526098730 hasRelatedWork W4254122466 @default.
• W1526098730 hasRelatedWork W4309660362 @default.
• W1526098730 hasRelatedWork W4310288564 @default.
• W1526098730 hasVolume "13" @default.
• W1526098730 isParatext "false" @default.
• W1526098730 isRetracted "false" @default.
• W1526098730 magId "1526098730" @default.
• W1526098730 workType "article" @default.